home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  

registry of biomedical companies

  March 01, 2024
promoting the transfer of scientific know-how between industry and academia
Registry of biomedical companies:

[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 469 active entries

Synergix Ltd.

Technology Park Malha, Building 1
Jerusalem, 91487 - Israel

Phone: +972 - 2 - 648 03 96
Fax: +972 - 2 - 648 03 99

E-Mail: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.


Synergix Ltd. is dedicated to developing educational resources for drug design, molecular modeling, cheminformatics and medicinal chemistry. Its main offering, The Molecular Conceptor Learning Series,  is an interactive computer-based learning suite that teaches the principles and techniques used in everyday drug discovery. The Series comprises five modules, each of which are designed to give students and professionals in the drug discovery field the comprehensive training necessary to face even the toughest drug design challenges. The modules are:

The Molecular Conceptor Learning Series presents the fundamental topics surrounding computer-aided drug design from basic principles to more in-depth examination and using interactive 3D technology, practical examples and many case studies, the concepts, methodologies and techniques used in drug discovery are brought to life.

International experts in the field of drug discovery have shared their skills, knowledge and experiences, and allowed the Synergix Ltd team to create The Molecular Conceptor Learning Series, an elearning tool that provides both students and professionals of the life sciences sector with the day-to-day knowledge and skills required to make an impact on modern drug discovery.

Selected Categories:
Product Company   Service Company
- General
- General
- General
- Miscellaneous
- Software

Last update of this entry: August 13, 2009

home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.